Sysmex : Announcement of Organizational and Personnel Changes (PDF：117KB)
March 09, 2022 at 01:11 am EST
Share
March 9, 2022
Sysmex Corporation
Announcement of Organizational and Personnel Changes
Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announces today its decision to implement organizational and personnel changes, effective April 1, 2022, as detailed below.
1. Organizational Changes
Reinforcing the Medical Affairs Function
We will newly establish the Medical Affairs 1 Department (Hematology, Urinalysis, and Life Science), the Medical Affairs 2 Department (Hemostasis), and the Medical Affairs 3 Department (Immunochemistry) within the Medical Affairs Division to increase the speed of planning and execution of strategies for clinical evaluation, clinical performance studies, and insurance coverage for each specialized field.
Strengthening the New Business Introduction Function
We will reinforce the new business introduction function within the Business Incubation Division. Accordingly, we will strengthen its cooperation with relevant functions with a view towards planning of the strategy and promoting the formulation for digital medicine and regenerative cell therapy.
Reinforcing the Reagent Production Function
Following the merger of Sysmex International Reagents Co., Ltd., we will consolidate functions concerning reagent production, including strategy planning, manufacturing technology, and production management into the Reagent Production Division.
2. Personnel Changes and Appointments
Appointments of Executive Officers (Newly Appointed)
Name
New Position
Current Position
Andy Hay
Executive Officer
CEO, Sysmex America, Inc.
(2) Changes in Operating and Functional Changes of Executive Officers
Name
New Position
Current Position
Kensuke Iizuka
Senior Executive Officer
Senior Executive Officer
Deputy in charge of Corporate
Deputy in charge of Corporate
Management
Management
Executive Vice President of
Executive Vice President of
Corporate Business Planning Div,
Corporate Business Planning Div,
Corporate Business Administration
Corporate Executive Office
Div,Corporate Executive Office
Kaoru Watanabe
Executive Officer
Executive Officer
Supervision of JEA
Supervision of JEA
Executive Vice President of JEA
Region Div.
Kinya Uchihashi
Executive Officer
Executive Officer
Executive Vice President of
Executive Vice President of
Reagent Production Div.
Reagent Production Div.
President and CEO, Sysmex
International Reagents Co., Ltd.
Andy Hay
Executive Officer
CEO, Sysmex America, Inc.
CEO, Sysmex America, Inc.
The information contained in this press release is current as of the date of the announcement but may be subject to change without prior
notice.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Sysmex Corporation published this content on 09 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2022 06:10:08 UTC.
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
SYSMEX CORPORATION 
